ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,445.80
0.21%
Dow Jones
39,839.15
0.71%
Gold vs US Dollar
2,385.30
1.27%
Brent Oil
82.615
0.08%
Bitcoin
65,475.15
6.38%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Karyopharm Therapeutics Inc (KPTI) Share Price

KPTI Karyopharm Therapeutics Inc

1.12
0.03 (2.75%)
Last Updated: 19:39:54
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Karyopharm Therapeutics Inc NASDAQ:KPTI NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.03 2.75 1.12 1.12 1.13 1.17 1.10 1.13 1,073,762 18:39:54   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 146.03M -143.1M -1.2436 -0.90 128.88M
 Type  Size  Price  Time  Units 
  100 1.12 18:40:03 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore KPTI News
14/05/202421:06EDGAR2Form 8-K - Current report
08/05/202421:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/05/202421:05PRNUSKaryopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
08/05/202412:52EDGAR2Form 8-K - Current report
08/05/202412:47EDGAR2Form 8-K - Current report
08/05/202412:30PRNUSKaryopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
08/05/202412:30PRNUSKaryopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
Period
Draw mode
Data Downloads for KPTI

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Karyopharm Therapeutics Inc Articles